UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000058509
Receipt number R000066897
Scientific Title MRI studies of neural tracts for higher-order visual information processing
Date of disclosure of the study information 2025/11/30
Last modified on 2025/07/19 09:14:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

MRI studies of neural tracts for higher-order visual information processing

Acronym

MRI visual research

Scientific Title

MRI studies of neural tracts for higher-order visual information processing

Scientific Title:Acronym

MRI visual research

Region

Japan


Condition

Condition

Healthy person

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The pathways for the processing of visual information in the brain, especially higher-order visual information such as reading and figure recognition, are often unknown. The aim of this research is to elucidate the information processing pathways in the brain for higher-order visual information in reading and figure recognition in humans.

Basic objectives2

Others

Basic objectives -Others

Correlation analysis of higher-order visual processing ability and its correlation with psychological indices.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Identification of processing pathways for advanced visual information in humans by brain MRI image analysis.

Key secondary outcomes



Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <

Age-upper limit

40 years-old >

Gender

Male and Female

Key inclusion criteria

Healthy adults.

Key exclusion criteria

The following are excluded:
1) Those who have previously been diagnosed with any neurosurgical, neurological or psychiatric disorder.
2) Those who regularly use sleeping pills.
3) Self-identified panic disorder or claustrophobia.
4) Those who have had metal instruments inserted into their bodies as a result of medical treatment of any kind.
5) Those with tattoos or art make-up.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name ATSUSHI
Middle name
Last name YAMAGUCHI

Organization

Chiba university

Division name

Graduate school of medicine

Zip code

260-8670

Address

1-8-1 Inohana, Chuo-ku, Chiba city

TEL

0432262024

Email

atsyama@restaff.chiba-u.jp


Public contact

Name of contact person

1st name ATSUSHI
Middle name
Last name YAMAGUCHI

Organization

Chiba university

Division name

Graduate school of medicine

Zip code

260-8670

Address

1-8-1 Inohana, Chuo-ku, Chiba city

TEL

0432262024

Homepage URL


Email

atsyama@restaff.chiba-u.jp


Sponsor or person

Institute

Chiba university

Institute

Department

Personal name

ATSUSHI YAMAGUCHI


Funding Source

Organization

Chiba university

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

National Institutes for Quantum Science and Technology

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Review Committee, Graduate School of Medicine, Chiba University

Address

1-8-1 Inohana, Chuo-ku, Chiba city

Tel

043-226-2501

Email

000@chiba-u.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW

千葉県


Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 11 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 07 Month 01 Day

Date of IRB


Anticipated trial start date

2026 Year 01 Month 01 Day

Last follow-up date

2030 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Preinitiation


Management information

Registered date

2025 Year 07 Month 18 Day

Last modified on

2025 Year 07 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000066897